Hosted on MSN16d
Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken
Moderna now forecasts 2025 revenues of $1.5 billion to $2.5 billion ... to an endemic phase. Last year, Moderna’s COVID-19 vaccine sales alone plummeted to $6.7 billion, down from $18 billion ...
Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
AOL9d
Where Will Moderna Be in 3 Years?
Moderna won't be revisiting its all-time highs for revenue or earnings in the next three years. The odds ... Today, Moderna's trailing-12-month revenue is just over $5 billion, and it reported ...